Henry Schein, Inc. (NASDAQ:HSIC – Get Free Report)’s stock price gapped down prior to trading on Thursday. The stock had previously closed at $83.66, but opened at $79.95. Henry Schein shares last traded at $82.6010, with a volume of 366,651 shares trading hands.
Analysts Set New Price Targets
Several equities analysts have weighed in on the stock. UBS Group set a $94.00 price objective on shares of Henry Schein and gave the stock a “neutral” rating in a research report on Wednesday, August 5th. Citigroup reissued a “buy” rating and set a $112.00 target price (up from $100.00) on shares of Henry Schein in a research note on Wednesday, August 5th. Stifel Nicolaus set a $95.00 target price on Henry Schein in a research report on Wednesday, August 5th. Wall Street Zen raised Henry Schein from a “hold” rating to a “buy” rating in a research report on Monday, August 17th. Finally, Barrington Research set a $104.00 price target on Henry Schein in a report on Wednesday, August 5th. Nine analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $92.93.
Check Out Our Latest Report on HSIC
Henry Schein Stock Performance
Henry Schein (NASDAQ:HSIC – Get Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $1.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.03. The business had revenue of $3.46 billion during the quarter, compared to analyst estimates of $3.37 billion. Henry Schein had a return on equity of 15.97% and a net margin of 2.96%. Henry Schein’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same period last year, the company earned $1.10 earnings per share. Henry Schein has set its FY 2026 guidance at 5.290-5.390 EPS. On average, research analysts anticipate that Henry Schein, Inc. will post 5.35 earnings per share for the current year.
Institutional Investors Weigh In On Henry Schein
Large investors have recently made changes to their positions in the company. GAMMA Investing LLC raised its position in Henry Schein by 13.0% during the third quarter. GAMMA Investing LLC now owns 5,111 shares of the company’s stock valued at $429,000 after acquiring an additional 587 shares in the last quarter. Operose Advisors LLC acquired a new stake in Henry Schein in the second quarter valued at approximately $33,000. Syon Capital LLC grew its position in Henry Schein by 73.1% in the second quarter. Syon Capital LLC now owns 4,932 shares of the company’s stock worth $412,000 after acquiring an additional 2,083 shares in the last quarter. Okabena Investment Services Inc. bought a new stake in Henry Schein in the second quarter worth approximately $209,000. Finally, New Mexico Educational Retirement Board increased its stake in shares of Henry Schein by 4.2% during the 2nd quarter. New Mexico Educational Retirement Board now owns 4,950 shares of the company’s stock worth $413,000 after purchasing an additional 200 shares during the last quarter. Institutional investors own 96.62% of the company’s stock.
Henry Schein Company Profile
Henry Schein, Inc (NASDAQ: HSIC) is a global provider of health care products and services serving dental and medical professionals, laboratories, health care institutions and veterinary practices. The company operates primarily as a distributor, helping customers obtain medical, dental and veterinary supplies, equipment, pharmaceuticals and related products.
In addition to product distribution, Henry Schein provides technology solutions and value-added services designed to support practice management, clinical workflows, procurement, compliance and business operations.
Further Reading
- Five stocks we like better than Henry Schein
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.
